Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
11:10 | Marpai, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
Mo | Marpai GAAP EPS of -$0.30, revenue of $7.01M | 2 | Seeking Alpha | ||
Mo | Marpai Reports Third Quarter 2024 Financial Results | 16 | PR Newswire | Turnaround continues to gain traction
TAMPA, Fla., Nov. 11, 2024 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a technology platform... ► Artikel lesen | |
03.09. | Marpai, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
12.08. | Earnings call: Marpai reports Q2 2024 financial results and turnaround progress | 1 | Investing.com | ||
08.08. | Marpai GAAP EPS of -$1.23, revenue of $7.2M | 1 | Seeking Alpha | ||
07.08. | Marpai, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
07.08. | Marpai, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
MARPAI Aktie jetzt für 0€ handeln | |||||
07.08. | Marpai Reports Second Quarter 2024 Financial Results | 83 | PR Newswire | Company continues to drive towards profitability
TAMPA, Fla., Aug. 7, 2024 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a technology platform company, which operates... ► Artikel lesen | |
25.06. | Marpai, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
03.06. | NSE - Marpai, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 1 | SEC Filings | ||
31.05. | Delisting of Securities of RiskOn International, Inc.; Graphjet Technology; Agile Therapeutics, Inc.; NextPlay Technologies, Inc.; Relativity Acquisition Corp.; iSun, Inc.; Ace Global Business Acquisition Limited; and Marpai, Inc. from The Nasdaq Stock Ma | 288 | GlobeNewswire (Europe) | NEW YORK, May 31, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of RiskOn International, Inc. RiskOn International, Inc.'s securities were suspended... ► Artikel lesen | |
30.05. | Marpai files to sell 3.94M shares of common stock for holders | 1 | Seeking Alpha | ||
28.05. | Why Is Marpai (MRAI) Stock Down 41% Today? | 1 | InvestorPlace | ||
28.05. | Marpai stock sinks 42% premarket on Nasdaq delisting | 1 | Seeking Alpha | ||
24.05. | Marpai, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
24.05. | Marpai Announces Withdrawal From Nasdaq Hearings Process And Will Transition Trading To The OTCQX Market | 638 | PR Newswire | Move reduces cost and burdens of Nasdaq listing
TAMPA, Fla., May 24, 2024 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), an independent national Third-Party Administration... ► Artikel lesen | |
22.05. | Marpai, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
09.05. | Marpai Reports First Quarter 2024 Financial Results | 91 | PR Newswire | Reduces Operating Expense by over $5 million and Net Loss by over 50% compared to 2023
TAMPA, Fla., May 9, 2024 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), an independent... ► Artikel lesen | |
26.03. | Marpai Reports Fourth Quarter And Full Year 2023 Financial Results | 97 | PR Newswire | Full Year Benefit of Maestro Acquisition and Q4 Corrective Actions Driving Financial Improvement
TAMPA, Fla., March 26, 2024 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI)... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 33,160 | -1,01 % | UBS stuft Fresenius SE auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Fresenius mit einem Kursziel von 34 Euro auf "Buy" belassen. Der Bericht des Medizin- und Klinikkonzerns zum dritten Quartal... ► Artikel lesen | |
TELADOC HEALTH | 9,245 | +0,47 % | Teladoc Health, Inc.: Teladoc Health Announces Employee Inducement Awards Under NYSE Rule 303A.08 | PURCHASE, NY, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today announced that it issued inducement awards to two new employees.... ► Artikel lesen | |
NUGEN MEDICAL DEVICES | 0,060 | -2,61 % | NuGen Medical: Rekordauftrag! Kommt da noch viel mehr? | ||
ATOSSA THERAPEUTICS | 1,474 | -2,77 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update | Announced positive topline results from KARISMA-Endoxifen Phase 2 study which demonstrated that low doses of (Z)-endoxifen significantly reduced mammographic breast density (MBD), addressing a key... ► Artikel lesen | |
CO-DIAGNOSTICS | 1,070 | -3,60 % | Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results | SALT LAKE CITY, Nov. 7, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
LOGICMARK | 0,184 | +37,72 % | LogicMark GAAP EPS of -$0.20 beats by $0.23, revenue of $2.7M beats by $0.26M | ||
ASSURANCE HEALTHCARE | 0,015 | 0,00 % | ASSURANCE HEALTHCARE LIMITED: CHANGE - CHANGE OF CATALIST SPONSOR::CHANGE OF CONTINUING SPONSOR | ||
NAYA BIOSCIENCES | 0,800 | -6,94 % | NAYA Biosciences, Inc. - 8-K, Current Report | ||
SIEMENS HEALTHINEERS | 50,48 | -2,92 % | UBS stuft Siemens Healthineers auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Siemens Healthineers mit einem Kursziel von 51 Euro auf "Neutral" belassen. Das vierte Geschäftsquartal sei solide verlaufen... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 40,080 | -0,45 % | Fresenius Medical Care: Überraschung | Mit einer derart starken Entwicklung hatten nur sehr wenige Experten gerechnet: Beim Dialysespezialisten Fresenius Medical Care (FMC) macht sich der Konzernumbau weiter bezahlt. Im Q3 sprang der operative... ► Artikel lesen | |
GERRESHEIMER | 74,85 | -1,84 % | Deutsche Post, Gerresheimer, Hugo Boss, Puma, SMA Solar, Süss MicroTec u.a. - Aktien-Positionen der Shortseller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
CARL ZEISS MEDITEC | 57,60 | -3,19 % | Starke Nachfrage treibt Kurs der Aktie von Carl Zeiss Meditec (58,65 €) | Die Aktie von Carl Zeiss Meditec zählt heute zu den großen Gewinnern am Aktienmarkt. Das Papier verteuert sich am Donnerstag deutlich. Jahreschart der Carl Zeiss Meditec AG-Aktie, Stand 07.11.2024 Grund... ► Artikel lesen | |
TEMPUS AI | 67,94 | -12,40 % | Tempus AI downgraded to hold by Stifel, valuation cited | ||
PROCEPT BIOROBOTICS | 95,60 | -1,90 % | PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance | SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
PROGYNY | 17,195 | +0,70 % | Progyny Non-GAAP EPS of $0.40 beats by $0.03, revenue of $286.62M misses by $10.77M |